Velocity Clinical Research - Syracuse — East Syracuse, New York

Velocity Clinical Research - Syracuse is a clinical research site located in East Syracuse, New York, United States 13057.

Crixeo Health Trust Score: 76/100 (FAIR). This profile has not yet been claimed by the site owner.

Velocity Clinical Research - Syracuse has participated in 9 clinical trials with 7 currently active.

Therapeutic areas: Diabetic Gastroparesis, SARS-CoV2, COVID-19.

Sponsors: CinDome Pharma, Inc., Vaxart, Vertex Pharmaceuticals Incorporated.

Sponsor Feasibility Report

Trust Score: 76/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Velocity Clinical Research - Syracuse?

Velocity Clinical Research - Syracuse has a Crixeo Trust Score of 76/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Velocity Clinical Research - Syracuse conducted?

Velocity Clinical Research - Syracuse has 9 clinical trials on record, with 7 currently active. Their work covers Diabetic Gastroparesis, SARS-CoV2, COVID-19.

Is Velocity Clinical Research - Syracuse accredited by Crixeo Health?

Yes — Velocity Clinical Research - Syracuse holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Velocity Clinical Research - Syracuse?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.